New biomarker predicts liver cancer recurrence and immunotherapy response
By Richard Schoonraad | Cancer, Cancer, Cancer and Cell Biology, Disease Area, Immunotherapy, Liver Cancer, Liver Cancer, Liver Disease, Liver Disease, News & Events, Research, Tumours, xOncofetal EcosystemAnalysis of the environment that surrounds liver cancer tumours has revealed that patients with a high concentration of a certain cell type have early return of aggressive cancer but do…
Federal government supports new treatment to clear blocked arteries
By Richard Schoonraad | Cardiovascular Disease, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Diabetes, Funding, News & Events, ResearchA Western Australian medical research team developing a new treatment for cardiovascular disease has received $2,147,254 in Federal government funding to develop a first-ever drug to clear blocked arteries. The…
WA researchers excel in nationally competitive grants
By Richard Schoonraad | Breast Cancer, Breast Cancer, Cancer, Cancer, Cancer Epigenetics, Cardiovascular Disease, Cardiovascular Disease, Epigenetics and Genomics Laboratory, Funding, Genome Biology and Genetic Diseases, Media Releases, Mitochondrial disease, Mitochondrial Disease, Mitochondrial Medicine and Biology, News & Events, Research, TranslationEight (8) Federal government grants awarded to the Harry Perkins Institute of Medical Research Two of Australia’s most significant research grants, given only to the nation’s highest performing researchers, have…
$3.5 million research collaborative brings cell therapy for solid cancers to WA
By Richard Schoonraad | Cancer, Cancer, Funding, Melanoma, Melanoma Discovery, Melonoma, News & Events, Personalised Medicine, ResearchResearchers from the Western Australia Melanoma Initiative (WAMI), a cancer research collaborative, will implement a specialised immune cell therapy for cancer patients in WA, thanks to a $2.5 million grant…
New discovery for treatment of primary liver cancer shows promise
By Richard Schoonraad | Cancer, Cancer, Cancer Epigenetics, Disease Area, Epigenetics and Genomics Laboratory, Lab, Liver, Liver Cancer, Liver Cancer, Liver Disease, Mitochondrial Medicine and Biology, News & Events, ResearchA study using preclinical models has discovered a drug combination with the potential to treat one of the most fatal and globally widespread cancers, a type of primary liver cancer…
Researchers find link to anti-ageing element
By Richard Schoonraad | Cancer, News & Events, Research, xOncofetal EcosystemResearchers discover that increasing a naturally occurring chemical slows ageing process Ageing is inevitable as systemic changes occur in our bodies, but the question that puzzled researchers at the Harry…
WA melanoma research featured at global Oncology congress
By Richard Schoonraad | Cancer, Cancer, Immunotherapy, Liver Cancer, Media Releases, Melanoma, Melanoma Discovery, Melonoma, News & Events, Research, Translation, TumoursBreakthrough research from the Harry Perkins Institute of Medical Research that explores possible new treatments for melanoma will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting.…

Further mysteries of cardiovascular disease-causing plaque revealed
By Richard Schoonraad | Blood Vessels, Cardiovascular Disease, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Heart, Media Releases, News & Events, ResearchNew discoveries on where plaque can form and what can trigger a heart attack. Researchers from the Harry Perkins Institute of Medical Research have published new findings that turn the…